𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia

✍ Scribed by Misato Kikuchi; Junji Tanaka; Takeshi Kondo; Satoshi Hashino; Masaharu Kasai; Mitsutoshi Kurosawa; Hiroshi Iwasaki; Masanobu Morioka; Tsugumichi Kawamura; Nobuo Masauzi; Takashi Fukuhara; Yasutaka Kakinoki; Hajime Kobayashi; Satoshi Noto; Masahiro Asaka; Masahiro Imamura


Book ID
107619120
Publisher
Carden Jennings Publishing
Year
2010
Tongue
English
Weight
276 KB
Volume
92
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A demographic study of the clinical sign
✍ Levett, D. ;Middleton, P. ;Cole, M. ;Reid, M.M. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## Background Minimal residual disease (MRD) detected during remission might predict outcome in children with acute lymphoblastic leukemia. No population‐based studies have been carried out. We studied all children with ALL presenting over 5 years within a defined population to determi

Monitoring of minimal residual disease i
✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo